Altered glutamate–glutamine and amide proton transfer-weighted values in the hippocampus of patients with amnestic mild cognitive impairment: A novel combined imaging diagnostic marker

BACKGROUND AND PURPOSE: Early diagnosis of amnestic mild cognitive impairment (aMCI) and timely management to delay the onset of Alzheimer's disease (AD) would benefit patients. Pathological metabolic changes of excitatory/inhibitory neurotransmitters and abnormal protein deposition in the hipp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xin, Gong, Tao, Chen, Tong, Xu, Changyuan, Li, Yuchao, Song, Qingxu, Lin, Liangjie, Oeltzschner, Georg, Edden, Richard A. E., Xia, Zhangyong, Wang, Guangbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995585/
https://www.ncbi.nlm.nih.gov/pubmed/36908797
http://dx.doi.org/10.3389/fnins.2023.1089300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995585/
https://www.ncbi.nlm.nih.gov/pubmed/36908797
http://dx.doi.org/10.3389/fnins.2023.1089300

Ejemplares similares